Novartis to gain heart drug in $1.4B deal for Tourmaline Bio

Tourmaline recently unveiled mid-stage trial data for its anti-inflammatory drug, which is ready for Novartis to advance into Phase 3 testing for heart disease.

Science-based risk assessment cornerstone of Nigeria’s approach to GMOs – NBMA DG – EnviroNews

February 7, 2026

World Wetlands Day: Oyo advised to curb indiscriminate vegetation clearance – EnviroNews

February 7, 2026

Source link

Novartis to gain heart drug in $1.4B deal for Tourmaline Bio

Science-based risk assessment cornerstone of Nigeria’s approach to GMOs – NBMA DG – EnviroNews

World Wetlands Day: Oyo advised to curb indiscriminate vegetation clearance – EnviroNews

New study shows that internet networks are growing in Africa, but high phone costs limit accessibility

‘The homeland is in the Pacific’

‘The homeland is in the Pacific’

Leave a Reply Cancel reply

RECOMMENDED NEWS

South Africa says it is addressing deficiencies that led to grey listing

Bitter Divorce Shakes Mining Industry! Managem and TSM Head to ICC Tribunal to Settle Explosive Dispute

Elon Musk’s Lawsuit Against a Group That Found Hate Speech on X Isn’t Going Well

What is the difference between AI ethics, responsible AI, and trustworthy AI?

POPULAR NEWS

Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

The world’s top 10 most valuable car brands in 2025

Top 10 African countries with the highest GDP per capita in 2025

Global ranking of Top 5 smartphone brands in Q3, 2024

When Will SHIB Reach $1? Here’s What ChatGPT Says

Novartis to gain heart drug in $1.4B deal for Tourmaline Bio

Related posts

New study shows that internet networks are growing in Africa, but high phone costs limit accessibility

‘The homeland is in the Pacific’

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS